Please login to the form below
AMR Action Fund
This page shows the latest AMR Action Fund news and features for those working in and with pharma, biotech and healthcare.
Pfizer acquires Amplyx Pharmaceuticals, including new potential class of therapeutics
Last year, the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) joined forces with leading pharma and biotech companies to launch the AMR Action Fund. ... In February, the AMR Action Fund raised a further $140m from new
Latest news
-
AMR Action Fund raises $140m from new investors to tackle antimicrobial resistance
The AMR Action Fund, launched last year, has raised $140m from new investors to bolster its efforts to bring new antibiotics through the clinical pipeline to patients. ... to address," said Henry Skinner, chief executive office of the AMR Action Fund.
-
Sandoz to acquire GSK’s cephalosporin antibiotic brands for up to $500m
The AMR Action Fund was created to bring two to four new antibiotics to patients by 2030 – treatments which are urgently needed to address the rapid rise of antibiotic resistance, which
-
New Oxford research institute established to tackle antimicrobial resistance
The IOI plans to partner with other global leaders in AMR research to achieve this goal. ... The AMR Action Fund was created to bring two to four new antibiotics to patients by 2030 – treatments that are urgently needed to address the rapid rise of
-
Perfect partners
Everything from developing vaccines in months rather than years, CEOs’ partnering in open letters reaffirming safety before speed, 20 biopharmaceutical companies creating the AMR Action Fund to bring new antibiotics to
-
MSD launches antibiotic combo Recarbrio in UK
The aptly named AMR Action Fund is aiming to bring two to four new antibiotics to patients by 2030. ... Current reimbursement frameworks simply do not support the level of sustained R&D investment that is needed to tackle AMR.
More from news
Approximately 2 fully matching, plus 6 partially matching documents found.
Latest Intelligence
-
The AMR Action Fund is combating antimicrobial resistance, but much more action is needed
However, the AMR Action Fund is not the permanent solution to the AMR threat. ... But the pipeline is on the verge of collapse and the AMR Action Fund is only a partial solution.
More from intelligence
Approximately 1 fully matching, plus 0 partially matching documents found.
Latest appointments
-
Henry Skinner has been appointed as the first CEO of the AMR Action Fund
I am honoured to join the AMR Action Fund and its incredibly important mission. ... I am proud and excited to lead the AMR Action Fund in its efforts to tackle the global challenge of AMR.
More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Principal Medical Writer/ Scientific Lead, Medcomms, £5K joining...
-
Highly competitive salary
- Market Access Director, six figure base salary and £5K joining b...
-
Highly competitive salary
- Lead Market Access Writer, £5K joining bonus, UK
-
Highly competitive salary
- Exciting Medical Writer Career Opportunity for Postdoc, Medcomms
-
Highly competitive salary
- World Health Organization releases latest set of COVID-19 guidelines
- BeiGene’s Brukinsa receives FDA approval for chronic lymphocytic leukaemia
- AstraZeneca/Daiichi Sankyo’s Enhertu approved by EC for advanced breast cancer
- Eli Lilly announces $450m investment in US manufacturing site
- Europe’s cancer community publishes new report on transforming patient care
- EU outlines measures to mitigate antibiotic shortage across Europe
- Innovative Trials comments on extra funding to increase access to clinical trials for cancer patients
- Gilead’s CAR-T cell therapy recommended by NICE for lymphoma
- JCVI recommends autumn COVID-19 vaccine booster for those at highest risk
- MIT researchers develop AI model to detect future lung cancer risk
- Merging global and local pharmacovigilance operations into a successful integrated approach
- Diversifying Healthcare AI with Federated Learning
- FDA and CDC investigate potential safety concern for Pfizer/BioNTech’s COVID-19 vaccine
- World Health Organization releases latest set of COVID-19 guidelines
- AbbVie and Eli Lilly leave UK’s voluntary drug pricing agreement
- EU to revise pharmaceuticals law amid antibiotic shortages
- European MPs call for urgent action against antimicrobial resistance
- The role of medical communications in building credibility for healthtech
PMHub
Envision Pharma Group
We are a global leader in the medical affairs space. Our purpose-built software and scientific solutions make us a unique...
Latest intelligence
- Virtual Steering Committee & Peer Influence Program
- In this customer story, we describe the methodology and results of our client’s ongoing Virtual Steering Committee & Peer Influence program....
- Meeting healthcare’s rising challenges
- The journey to discover novel therapies through digital innovation and ensure scientific advances achieve their potential...
- Report gives insights to address gaps in HCP engagement
- How does Pharma-HCP engagement need to evolve in today's digital landscape?...
